Investopedia

Continue to Site »

« Back

Stock Analysis tagged as

Sector - Healthcare and Social Assistance

  1.

    Medtronic Still Reporting Weak Growth, But A Relatively Rare Bargain

  2. Roche, Reloaded

  3. Elan Continues To Make Baffling Strategic Decision

  4. After A Big Rally, Pfizer Might Need Some Rest

  5. Adasuve Deal Is Very Good For Alexza, But What About Teva?

  6. Recent Financials May Not Be Entirely Fair To Hologic

  7. Amgen Chased By The Bubble

  8. Teva Still Too Cheap, But Still Too Uncertain

  9. It Gets A Little Harder From Here For Covidien

  10. Thermo Steps Up And Seals A Deal For Life Technologies

  11. Broad Weakness Makes It Harder To Like St. Jude Today

  12. Pharma Is Doing All The Pulling For Johnson & Johnson

  13. 4 ETFs To Play A Booming Healthcare Sector

  14. Pfizer Readies Zoetis For Market

  15. Herbalife Is Merely A Pawn In This Hedge Fund Battle Royal

  16. Should Third Quarter Results From Forest Laboratories Worry Investors?

  17. Abbott Labs Spins Off AbbVie: Which Is The Better Buy?

  18. A Look Back At The Year In Pharmaceuticals

  19. A Look Back At The Year In Medical Technology

  20. A Look Back At The Year In Biotech

  21. A Triple Play Of Biotech Disappointments Last Week

  22. How Far Can Philips' Turnaround Take The Stock?

  23. Smith & Nephew's Costly Deal

  24. Endo Health Solutions Needs Some Solutions Of Its Own

  25. Bayer Buys Schiff Nutrition International: Winners All Around

  26. Will It Be Even Harder For Life Tech To Muddle Through In 2013?

  27. Is “Less Bad” As Good As It Gets For Dendreon?

  28. Love Or Hate - Wall Street Will Love A Republican President

  29. Drugs Have Moved J&J On To A New Phase

  30. Washington Post Gets Into The Healthcare Business

  31. Danaher Does Another Typical Danaher Deal

  32. The Week In Healthcare

  33. Investor Unrest Leads The WellPoint CEO To Resign

  34. The Week Ahead In Healthcare

  35. The Week Ahead In Healthcare (August 20)

  36. Pfizer Looks To Spin Off Animal Health Unit

  37. The Week Ahead In Healthcare

  38. The Week Ahead In Healthcare

  39. More Healthy Alternatives To Zimmer

  40. The Week Ahead In Healthcare

  41. The Week Ahead In Healthcare

  42. The Week Ahead In Healthcare

  43. Hi-Tech Pharmacal An Under Followed Name Worth Following

  44. WellPoint Buys More Medicaid Exposure

  45. The Week Ahead In Healthcare

  46. Lincare Shows That You Can Go Home Again

  47. Healthcare Outlook For The Week Ahead

  48. Can Body Sculpting Bulk Up Solta Medical?

  49. Medicine Gets Personalized

  50. Bio-Reference Labs Taking Advantage Of Esoteric Opportunities

  51. Want A High-Yield Healthcare Stock? Look To Canada

  52. Stocks On Fire As The Market Bounces

  53. AmerisourceBergen Looks Very Healthy

  54. Lifepoint Hospitals Heads For The Country

  55. Becton Dickinson Safe And Steady

  56. Davita Goes Shopping

  57. Stocks That Keep You Looking Good

  58. The Trend In Rising Cancer Incidences

  59. Market-Crushing ETFs

  60. A Healthy Growth Strategy

  61. Control May Be Herbalife's Real Long-Term Problem

  62. Time To Buy Pharmaceuticals?

  63. Premium-Price athenahealth Leaves Little Room For Error

  64. CVS Caremark On A Healthy Upward Path

  65. Obagi Puts Its Problems Behind It

  66. Stocks Showing Resilience

  67. ilent Pays A Hefty Price For A Fixer-Upper Diagnostics Company

  68. Oversold Market Leads To Opportunities

  69. Treat Stocks Like Savings

  70. Top Rated Highly Shorted Stocks

  71. AstraZeneca Searches For Answers

  72. Amylin Puts Up 'For Sale' Sign

  73. LabCorp Fighting Industry Headwinds

  74. Will United Health's Cost Trends Cooperate?

  75. Glaxo Plays Hardball With Human Genome Sciences

  76. Buy Into Weakness

  77. 4 ETF's To Look At

  78. Healthcare Services Group - Great Business … Great Stock?

  79. Smart Stocks To Rally With

  80. A Strong Prognosis For Healthcare REITs

  81. Birth Control Subsidies Slashed: Will Big Pharma Take A Hit?

  82. Wall Street Isn't Buying The Medifast Story

  83. Stocks For An Uncertain World

  84. Value At Abbott Labs Balances A Lot Of Growth Optimism

  85. LabCorp Passes the Test

  86. Transcend Services: A Physician's Best Friend

  87. Pfizer Shrugs Off the Loss Of Lipitor

  88. Earnings The Doctor Ordered

  89. 4 Overbought Stocks To Watch

  90. The Long-Term Play In Lab Work

  91. Europe Won't Kill Siemens

  92. Bristol-Myers Pays Up To Patch A Gap

  93. Don't Count Out Healthcare Stocks

  94. Best S&P 500 Stocks Of 2011

  95. Top Income Plays For 2012

  96. Slow And Steady ETFs Outperforming

  97. 4 Heavily Shorted Stocks That Could Climb Higher

  98. 4 ETFs On Fire Right Now

  99. The War Against Alzheimer's Requires Thinking Small

  100. Neogen Is Almost Cheap

Marketplace
Investopedia Features

  1. Choosing Quality Mutual Funds

    Our step-by-step mutual fund scoring system will help you uncover the top-quality funds.

  2. Guide to Stock Picking Strategies

    Learn about the most popular stock-picking strategies, including their philosophies, methods, and tools.

  3. Advanced Financial Statement Analysis

    Learn what it means to do your homework before investing in a company.

  4. World's Greatest Investors

    Here you can read about the backgrounds and achievements of those people who have mastered the art of investing.

  5. The Industry Handbook

    Take a look at the various techniques to determine the value and quality of companies from an industry perspective.
Visit the Features Area
Trading Center